Fibrinogen concentrate vs. fresh frozen plasma for the management of coagulopathy during thoraco-abdominal aortic aneurysm surgery: a pilot randomised controlled trial

Anaesthesia

Volumn 74, Issue 2, 2019, Pages 180-189

  Morrison, G A ^a   Koch, J ^a   Royds, M ^a   McGee, D ^b   Chalmers, R T A ^a   Anderson, J ^a   Nimmo, A F ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

fibrinogen concentrate; fresh frozen plasma; thoraco abdominal aortic aneurysm surgery; vascular anaesthesia

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; HEPARIN;

ACTIVATED PARTIAL THROMBOPLASTIN TIME; AGED; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD COMPONENT THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOVASCULAR ANEURYSM REPAIR; FEMALE; HEMOSTASIS; HUMAN; HYPOFIBRINOGENEMIA; INTERNATIONAL NORMALIZED RATIO; MALE; OPERATIVE BLOOD LOSS; PILOT STUDY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THORACOABDOMINAL AORTA ANEURYSM; THROMBOCYTE TRANSFUSION; VASCULAR SURGERY; COMPARATIVE STUDY; PLASMA; THORACIC AORTA ANEURYSM;

AGED; AORTIC ANEURYSM, THORACIC; BLOOD COAGULATION DISORDERS; FEMALE; FIBRINOGEN; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; PLASMA;

EID: 85056872671     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.14495     Document Type: Article

References (33)

1. Cina CS, Clase CM. Coagulation disorders and blood product use in patients undergoing thoracoabdominal aortic aneurysm repair. Transfusion Medicine Reviews 2005; 19: 143–54.
2. Cina CS, Clase CM, Bruin G. A cohort study of coagulation parameters and the use of blood products in surgery of the thoracic and thoracoabdominal aorta. Journal of Vascular Surgery 2001; 33: 462–8.
3. Pandey S, Vyas GN. Adverse effects of plasma transfusion. Transfusion 2012; 52: 65S–79S.
4. Chapter author not specified. Chapter 3 ‘Providing Safe Blood’. In: Norfolk D, ed. Handbook of transfusion medicine, 5th edn. Norwich, UK: TSO, 2013: 19–21.
5. Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesthesia and Analgesia 1995; 81: 360–5.
6. Bolliger D, Görlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010; 113: 1205–19.
7. Fenger-Eriksen C, Tonnesen E, Ingerslev J, Sorensen B. Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. Journal of Thrombosis and Haemostasis 2009; 7: 1099–105.
8. Mittermayr M, Streif W, Haas T, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopaedic surgery: the role of fibrinogen administration. Anesthesia and Analgesia 2007; 105: 905–17.
9. Manco-Johnson MJ, Dimichele D, Castaman G, et al. Fibrinogen Concentrate Study Group. Pharmacokinetics and safety of fibrinogen concentrate. Journal of Thrombosis and Haemostasis 2009; 7: 2064–9.
10. Dickneite G, Pragst I, Joch C, Bergman GE. Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate. Blood Coagulation and Fibrinolysis 2009; 20: 535–40.
11. Ranucci M, Solomon C. Supplementation of fibrinogen in acquired bleeding disorders: experience, evidence, guidelines, and licences. British Journal of Anaesthesia 2012; 109: 135–7.
12. Green L, Bolton-Maggs P, Beattie C, et al. British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding. British Journal of Haematology 2018; 181: 54–67.
13. Doyle S, O'Brien P, Murphy K, Fleming C, O'Donnell J. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coagulation and Fibrinolysis 2003; 14: 283–7.
14. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesthesia and Analgesia 2008; 106: 1366–75.
15. Richards JMJ, Nimmo AF, Moores CR, et al. Contemporary results for open repair of suprarenal and type IV thoracoabdominal aortic aneurysms. British Journal of Surgery 2010; 97: 45–9.
16. Görlinger K, Dirkmann D, Hanke AA, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011; 115: 1179–91.
17. Schöchl H, Nienaber U, Maegele M, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Critical Care 2011; 15: R83.
18. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. British Journal of Anaesthesia 2009; 102: 793–9.
19. Lang T, Johanning K, Metzler H, et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesthesia and Analgesia 2009; 108: 751–8.
20. Rahe-Meyer N, Levy JH, Mazer CD, et al. Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. British Journal of Anaesthesia 2016; 117: 41–51.
21. Bilecen S, de Groot JA, Kalkman CJ, et al. Effect of fibrinogen concentrate on intraoperative blood loss among patients with intraoperative bleeding during high-risk cardiac surgery: a randomized clinical trial. Journal of the American Medical Association 2017; 317: 738–47.
22. Collins PW, Cannings-John R, Bruynseels D. Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial. British Journal of Anaesthesia 2017; 119: 411–21.
23. Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A. Surgical Clinical Outcome REsearch (SCORE) group. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. Journal of the American Heart Association 2015; 4: e002066.
24. Ranucci M, Baryshnikova E. Fibrinogen supplementation after cardiac surgery: insights from the Zero-Plasma trial (ZEPLAST). British Journal of Anaesthesia 2016; 116: 618–23.
25. Ranucci M, Pistuddi V, Baryshnikova E, Colella D, Bianchi P. Fibrinogen levels after cardiac surgical procedures: association with postoperative bleeding, trigger values, and target values. Annals of Thoracic Surgery 2016; 102: 78–85.
26. Klein AA, Arnold P, Bingham RM, et al. AAGBI guidelines: the use of blood components and their alternatives 2016. Anaesthesia 2016; 71: 829–42.
27. Mumford AD, Ackroyd S, Alikhan R, et al. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology. British Journal of Haematology 2014; 167: 304–26.
28. Collins P, Abdul-Kadir R, Thachil J. Subcommittees on women’ s health issues in thrombosis and haemostasis and on disseminated intravascular coagulation. Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis 2016; 14: 205–10.
29. Davenport RA, Guerreiro M, Frith D, et al. Activated protein C drives the hyperfibrinolysis of acute traumatic coagulopathy. Anesthesiology 2017; 126: 115–27.
30. Collins PW, Solomon C, Sutor K. Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. British Journal of Anaesthesia 2014; 113: 585–95.
31. Schött U, Solomon C, Fries D, Bentzer P. The endothelial glycocalyx and its disruption, protection and regeneration: a narrative review. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2016; 24: 48.
32. Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. European Journal of Anaesthesiology 2017; 34: 332–95.
33. Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Critical Care 2016; 20: 100.